Direct access to our subject matter experts
Ask the Analyst gives Citeline subscribers direct access to a global team of experts, delivering personalized, data-backed answers to the most pressing industry questions. From R&D trends and trial intelligence to regulatory shifts and market forecasts, get the clarity and competitive edge you need - all within 48 hours.
Get expert insights when you need them most.
Here is what you get
Exclusive Access
for Citeline subscribers
48h
Response time
24/7
Availability
Tailored personalized insights
Top therapeutic areas covered
Explore top inquiry types and sample questions
Business Strategies
What is the current regulatory landscape for non-small cell lung cancer (NSCLC) in the US and globally?
Drugs
Is the berzosertib (M6620) an ATRi by Merck KGaA still active or has the ATRi pgm at Merck been refocused on tuvusertib (M1774)?
Investigators and Sites
Can you help me set up a search to analyze which sites globally have the greatest ratio of sponsor-initiated research?
Trials
Do you have any data with real world evidence (RWE) trials in Citeline? Specifically, for migraine Phase IV trials?
Diseases
Could you provide a report that details drugs in development for graft versus host disease (cGVHD) after failure of one or more lines of systemic therapy?
Regulation and Policy
I’m looking for potential impacts of the US Inflation Reduction Act (IRA) on rare diseases.
Study Feasibility
Could you please help with a phase II study's RR, PI recommendation and competing studies in US and EU?
Trial Timing
What is the average recruitment rate for industry sponsored USA based clinical trials that recruited patients with metastatic (Stage IV) colorectal cancer that has progressed on at least 2 prior systemic treatment regimens over the last 5 years?
Trusted by industry leaders
The work you do for us matters and makes a huge difference in what we deliver to our management. We appreciate the contributions from Ask the Analyst team.
Thank you so much for sending this report in such a timely fashion. This is exactly what we have been trying to get.
These results are perfect and allow me to customize as needed.
Thank you so much for your valuable help. I have used the Ask the Analyst tool more than once, and every single time, you all do a fantastic job. Thanks for the pull and the explanation; that makes a lot of sense! Much appreciated.
Let's get you the answers you need
At Citeline, we understand the complexities of the pharmaceutical and healthcare landscape. That’s why we offer Ask the Analyst, a complimentary service for subscribers, providing you with direct access to industry experts who deliver data-driven insights and strategic solutions to address your unique business challenges.
A specialist is ready to speak to you regarding your interests and find the solutions that are right for you.
